Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone and Estrogen Effects on GH Secretion in Older Women
NCT02272647Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Dec 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of progesterone in frailty syndrome (4 arms), sponsored by Mayo Clinic. Primary endpoint: Logarithm of the ratio of the normalized growth hormone secretion rate over the first 10 hr at Day 23. Started Dec 2014; status: completed.
02
Drugs
progesterone
03
Conditions
frailty syndrome
Beyond the preview
Go deeper on NCT02272647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02272647.